• Exchange: Xetra
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Epigenomics AG

+ Add to Watchlist

ECX:GR

5.024 EUR 0.277 5.23%

As of 11:36:14 ET on 01/23/2015.

Snapshot for Epigenomics AG (ECX)

Open: 5.300 Day's Range: 4.853 - 5.474 Volume: 201,001
Previous Close: 5.301 52wk Range: 2.800 - 8.870 1-Yr Rtn: -21.25%

Stock Chart for ECX

No chart data available.
  • ECX:GR 5.150
  • 1D
  • 1M
  • 1Y
5.301
Interactive ECX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ECX

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (EUR) (ttm) -0.6000
Est. EPS (EUR) (12/2014) -0.6320
Est. PEG Ratio -
Market Cap (M EUR) 77.77
Shares Outstanding (M) 15.48
30 Day Average Volume 121,280
Price/Book (mrq) 22.4503
Price/Sale (ttm) 38.4050
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/26/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ECX

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for ECX

Epigenomics AG is a molecular diagnostics company developing and commercializing a pipeline of proprietary products for cancer. The Company's products enable doctors to diagnose cancer earlier and more accurately, leading to improved outcomes for patients.

Thomas TaapkenCEO/CFO/Member-Mgmt BoardUwe StaubChief Operating Officer
Antje ZeiseManager:Investor Relations
More Company Profile & Key Executives for ECX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil